Cefpirome
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H22N6O5S2 |
Molar mass | 514.58 g/mol |
3D model (Jmol) | |
|
|
|
|
|
Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, and Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria.
Spectrum of bacterial susceptibility and resistance[edit]
Bacteroides fragilis, enterococci, Pseudomonas spp. and staphylococci are resistant to cefpirome sulfate, and some Haemophilus spp. and pneumococci have developed resistance to it to varying degrees.[1]
References[edit]
- ^ "Cefpirome Sulfate spectrum of bacterial susceptibility and Resistance" (PDF). Retrieved 10 April 2012.
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |